2007, Piran, Slovenia
2007, Piran, Slovenia 2007, Piran, Slovenia
Environmental Ergonomics XII Igor B. Mekjavic, Stelios N. Kounalakis & Nigel A.S. Taylor (Eds.), © BIOMED, Ljubljana 2007 344 ADAPTATION OF ADRENERGIC FUNCTIONS IN WINTER SWIMMERS Ladislav Janský 1 , Stanislav Vybíral 2 , Jan Okrouhlík 1 , Milena Trubačová 2 1 Biological Faculty, University of South Bohemia, Budweis, 2 Faculty of Science, Charles University, Prague, Czech Rep. Contact person: janskyl@seznam.cz INTRODUCTION Our previous observations revealed that adaptation of humans to cold due the repeated whole body cold water immersions induces a downward shift of the hypothalamic threshold for induction of cold thermogenesis (hypothermic adaptation) (Janský et al. 1996, Vybíral et al. 2000). Further it was found that in cold adapted winter swimmers the adrenergic thermogenesis was potentiated (metabolic adaptation) and vasoconstriction became more effective (insulative adaptation) (Lesná et al. 1999). The role of the sympathetic nervous system and adrenergic receptors in mediating these functions has been well established (for review see Janský and Janský 2002). The question remains, whether the role of adrenoceptors is influenced by cold adaptation. In this study we concentrated on clarifying the role of beta1 and beta2 adrenoceptors in mediating adrenergic thermogenesis and cardiovascular functions in cold adapted winter swimmers. METHODS Metabolic rate, skin temperatures, rectal temperature, heart rate and systolic blood pressure were measured in a control group (n=6, age 21,5 years, body mass 70,0 kg, height 183 cm, body mass index 25,7) and in winter swimmers (n=6, age 42,8 years, body mass 83,0 kg, height 179,1 cm, body mass index 25,9) at rest and after iv infusions of increasing doses (0,5; 1,4; 2,0; 4,0; 5,0 µg. min -1 . kg -1 body mass) of the adrenergic agonist with the predominating β1 adrenergic activity (Dobutamine, PLIVA-Lachema a.s., Brno) or of the β2 agonist (Bricanyl, AstraZeneca UK Ltd) (in concentrations 0,04; 0,08; 0,16; 0,40 µg. min -1 . kg -1 body mass). During experiments the subjects, wearing trunks, rested in bed at thermoneutral conditions. Increasing concentrations of the β1 agonist were administered subsequently via the permanently cannulated antecubital vein, each concentration being infused for 10 min. The same procedure was applied in case of the β2 agonist. Metabolic rate was measured using a modified paramagnetic oxygen analyzer (Dvořák, Czech Rep.). Temperature sensors (HD 590, Angloy Devices, USA) were used to measure rectal temperature and skin temperatures on the middle finger and on the chest. A computerized data acquisition system was used to collect and analyze the metabolic and temperature data. Heart rate and blood pressures were monitored using a cardiomonitor Eagle 3000. Experiments on controls were performed in October and experiments on winter swimmers were performed in February. Data are presented as means ± SEM. Statistical significance of data, obtained on controls and winter swimmers were compared using analysis of variance (ANOVA). The post hoc analysis of differences between means were carried out using Student´s two tailed non-paired test with p
Cold water immersion RESULTS Experiments revealed that infusions of the optimal dose of the β1 agonist (Dobutamine) increased metabolic rate of humans resting at thermoneutal conditions by 39 %, while infusions of the β2 agonist (Bricanyl) increased metabolic rate by 20%, in absolute terms the increase being 77 ml O2. kg -1 .hr -1 , or 57 ml O2. kg -1 .hr -1 , respectively (Fig. 1, 2). This indicates greater role of β1 adrenoceptors in mediating metabolic response. In winter swimmers administrations of both adrenomimetics were without effect, indicating downregulation of adrenergic receptors (Fig. 1, 2). Metabolic rate (mlO 2.kg -1 .hr -1 ) 390 370 350 330 310 290 270 250 230 210 β1 adrenergic agonist -0,5 0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5 5,0 5,5 Infusion rate (µg.kg -1 .min -1 ) Figure 1. Effect of increasing concentrations of the β1 agonist on metabolic rate in controls (white points, interrupted line) and winter swimmers (black points, solid line). Metabolic rate (ml O 2.kg -1 .hr -1 ) 390 370 350 330 310 290 270 250 230 210 β2 adrenergic agonist -0,05 0,00 0,05 0,10 0,15 0,20 0,25 0,30 0,35 0,40 0,45 Infusion rate (µg.kg -1 .min -1 ) Figure 2. Effect of increasing concentrations of the β2 agonist on metabolic rate in controls (white points, interrupted line) and winter swimmers (black points, solid line). In contrast to the effect on metabolic rate, the actions of the β1 and of the β2 agonist on heart rate were different. The β1 agonist was without effect, while the β2 agonist increased heart rate by about 100%, indicating dominant role of β2 adrenoceptors in controlling heart rate (Fig. 3, 4). In winter swimmers the effect of the β2 agonist was supressed by about a half (Fig. 3, 4). 345
- Page 293 and 294: Sweating REGIONAL DIFFERENCES IN TO
- Page 295 and 296: Sweating Figure 2: Inter-site sweat
- Page 297 and 298: Sweating MENSTRUAL CYCLE DOES NOT A
- Page 299 and 300: Sweating RESULTS On average, the ma
- Page 301 and 302: Sweating THE SWEAT SECRETION AND SO
- Page 303 and 304: Sweating Figure 1: A quadrant diagr
- Page 305 and 306: Invited presentation FINGER COLD IN
- Page 307 and 308: Cold physiology INTRA-INDIVIDUAL DI
- Page 309 and 310: Cold physiology number was estimate
- Page 311 and 312: Cold physiology cold receptors decr
- Page 313 and 314: Cold physiology EFFECT OF URAPIDIL
- Page 315 and 316: Cold physiology THE EFFECT OF EXERC
- Page 317 and 318: TRAINABILITY OF COLD INDUCED VASODI
- Page 319 and 320: Cold physiology REFERENCES Adams, T
- Page 321 and 322: Cold physiology THE EFFECT OF REPEA
- Page 323 and 324: Cold physiology THE EFFECT OF ALTIT
- Page 325 and 326: Cold physiology SKIN SURFACE MENTHO
- Page 327 and 328: Cold physiology COGNITIVE PERFORMAN
- Page 329 and 330: Seconds 6.5 6.0 5.5 5.0 4.5 4.0 3.5
- Page 331 and 332: Cold water immersion REFERENCES Mek
- Page 333 and 334: Cold water immersion the formula: M
- Page 335 and 336: Cold water immersion REFERENCES Cho
- Page 337 and 338: Cold water immersion were: 1 metre
- Page 339 and 340: Cold water immersion surf beaches.
- Page 341 and 342: Cold water immersion Table 1. Break
- Page 343: Cold water immersion ARM INSULATION
- Page 347 and 348: Cold water immersion thermogenesis
- Page 349 and 350: Cold water immersion The other comp
- Page 351 and 352: Cold water immersion REFERENCES And
- Page 353 and 354: Thermal comfort THERMAL SENSATIONS
- Page 355 and 356: Exer - cise PC Wind (m·s -1 ) 0 ne
- Page 357 and 358: Thermal comfort and heart rate usin
- Page 359 and 360: Thermal comfort A NEW METHOD FOR EV
- Page 361 and 362: Thermal comfort DEVELOPMENT OF AN I
- Page 363 and 364: Thermal comfort DISCUSSION This new
- Page 365 and 366: Thermal comfort limit of exposure d
- Page 367 and 368: Table 2: Statistical summary. Gende
- Page 369 and 370: Thermal comfort comfortable”), wh
- Page 371 and 372: Thermal comfort RELATION BETWEEN TH
- Page 373 and 374: Thermal comfort Figure 2. Skin wett
- Page 375 and 376: Thermal comfort THE EVALUATION OF T
- Page 377 and 378: Temp.ˇ ]˘ Jˇ ^ 42 40 38 36 34 32
- Page 379 and 380: time(min) Thermal comfort WHY DO JA
- Page 381 and 382: Thermal comfort TCT : THERMAL COMFO
- Page 383 and 384: Thermal comfort INTERNATIONAL STAND
- Page 385 and 386: Acute and chronic heat exposure PHY
- Page 387 and 388: Acute and chronic heat exposure Fig
- Page 389 and 390: Acute and chronic heat exposure EFF
- Page 391 and 392: Acute and chronic heat exposure 2.2
- Page 393 and 394: Acute and chronic heat exposure EFF
Environmental Ergonomics XII<br />
Igor B. Mekjavic, Stelios N. Kounalakis & Nigel A.S. Taylor (Eds.), © BIOMED, Ljubljana <strong>2007</strong><br />
344<br />
ADAPTATION OF ADRENERGIC FUNCTIONS IN WINTER<br />
SWIMMERS<br />
Ladislav Janský 1 , Stanislav Vybíral 2 , Jan Okrouhlík 1 , Milena Trubačová 2<br />
1 Biological Faculty, University of South Bohemia, Budweis, 2 Faculty of Science, Charles<br />
University, Prague, Czech Rep.<br />
Contact person: janskyl@seznam.cz<br />
INTRODUCTION<br />
Our previous observations revealed that adaptation of humans to cold due the repeated whole<br />
body cold water immersions induces a downward shift of the hypothalamic threshold for<br />
induction of cold thermogenesis (hypothermic adaptation) (Janský et al. 1996, Vybíral et al.<br />
2000). Further it was found that in cold adapted winter swimmers the adrenergic<br />
thermogenesis was potentiated (metabolic adaptation) and vasoconstriction became more<br />
effective (insulative adaptation) (Lesná et al. 1999). The role of the sympathetic nervous<br />
system and adrenergic receptors in mediating these functions has been well established (for<br />
review see Janský and Janský 2002). The question remains, whether the role of adrenoceptors<br />
is influenced by cold adaptation. In this study we concentrated on clarifying the role of beta1<br />
and beta2 adrenoceptors in mediating adrenergic thermogenesis and cardiovascular functions<br />
in cold adapted winter swimmers.<br />
METHODS<br />
Metabolic rate, skin temperatures, rectal temperature, heart rate and systolic blood pressure<br />
were measured in a control group (n=6, age 21,5 years, body mass 70,0 kg, height 183 cm,<br />
body mass index 25,7) and in winter swimmers (n=6, age 42,8 years, body mass 83,0 kg,<br />
height 179,1 cm, body mass index 25,9) at rest and after iv infusions of increasing doses (0,5;<br />
1,4; 2,0; 4,0; 5,0 µg. min -1 . kg -1 body mass) of the adrenergic agonist with the<br />
predominating β1 adrenergic activity (Dobutamine, PLIVA-Lachema a.s., Brno) or of the β2<br />
agonist (Bricanyl, AstraZeneca UK Ltd) (in concentrations 0,04; 0,08; 0,16; 0,40 µg. min -1 .<br />
kg -1 body mass). During experiments the subjects, wearing trunks, rested in bed at<br />
thermoneutral conditions. Increasing concentrations of the β1 agonist were administered<br />
subsequently via the permanently cannulated antecubital vein, each concentration being<br />
infused for 10 min. The same procedure was applied in case of the β2 agonist.<br />
Metabolic rate was measured using a modified paramagnetic oxygen analyzer (Dvořák,<br />
Czech Rep.). Temperature sensors (HD 590, Angloy Devices, USA) were used to measure<br />
rectal temperature and skin temperatures on the middle finger and on the chest. A<br />
computerized data acquisition system was used to collect and analyze the metabolic and<br />
temperature data. Heart rate and blood pressures were monitored using a cardiomonitor Eagle<br />
3000. Experiments on controls were performed in October and experiments on winter<br />
swimmers were performed in February.<br />
Data are presented as means ± SEM. Statistical significance of data, obtained on controls<br />
and winter swimmers were compared using analysis of variance (ANOVA). The post hoc<br />
analysis of differences between means were carried out using Student´s two tailed non-paired<br />
test with p